IFITM3 and hepatocellular carcinoma: For IFITM3 rs 12252-CC gene polymorphisms, the results in this study as showed in Fig. 3A the homozygous TT genotypic frequency in hepatocellular carcinoma patients (11%) that was less than which founded in control group (23%).